Technical Analysis for BLPH - Bellerophon Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 0.06 | 13.80% | 0.01 |
BLPH closed up 13.8 percent on Monday, March 18, 2024, on 9 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: Mar 29
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Crossed Above 50 DMA | Bullish | 0.00% | |
MACD Bullish Centerline Cross | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% |
Alert | Time |
---|---|
Rose Above 20 DMA | about 16 hours ago |
Rose Above 50 DMA | about 16 hours ago |
Rose Above 10 DMA | about 16 hours ago |
60 Minute Opening Range Breakout | about 16 hours ago |
Rose Above Upper Bollinger Band | about 16 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/29/2024
Bellerophon Therapeutics LLC, a clinical-stage therapeutics company, focuses on the development of various products for the treatment of cardiopulmonary and cardiac diseases. Its product candidates include INOpulse for the treatment of pulmonary arterial hypertension, as well as to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases; and bioabsorbable cardiac matrix, a medical device for the prevention of congestive heart failure. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics LLC in January 2014. Bellerophon Therapeutics LLC was founded in 2009 and is based in Hampton, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cardiovascular Disease Hypertension Heart Failure Chronic Obstructive Pulmonary Disease Respiratory Diseases Pulmonary Arterial Hypertension Pulmonary Disease Aging Associated Diseases Pulmonology Congestive Heart Failure Pulmonary Hypertension Cardiovascular System Oab Cardiac Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cardiovascular Disease Hypertension Heart Failure Chronic Obstructive Pulmonary Disease Respiratory Diseases Pulmonary Arterial Hypertension Pulmonary Disease Aging Associated Diseases Pulmonology Congestive Heart Failure Pulmonary Hypertension Cardiovascular System Oab Cardiac Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 12.58 |
52 Week Low | 0.029 |
Average Volume | 76,960 |
200-Day Moving Average | 0.37 |
50-Day Moving Average | 0.06 |
20-Day Moving Average | 0.05 |
10-Day Moving Average | 0.05 |
Average True Range | 0.01 |
RSI (14) | 53.70 |
ADX | 19.14 |
+DI | 22.43 |
-DI | 8.74 |
Chandelier Exit (Long, 3 ATRs) | 0.04 |
Chandelier Exit (Short, 3 ATRs) | 0.06 |
Upper Bollinger Bands | 0.06 |
Lower Bollinger Band | 0.05 |
Percent B (%b) | 0.93 |
BandWidth | 16.17 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0004 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.07 | ||||
Resistance 3 (R3) | 0.07 | 0.07 | 0.07 | ||
Resistance 2 (R2) | 0.07 | 0.06 | 0.07 | 0.07 | |
Resistance 1 (R1) | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 |
Pivot Point | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
Support 1 (S1) | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 |
Support 2 (S2) | 0.04 | 0.05 | 0.04 | 0.04 | |
Support 3 (S3) | 0.04 | 0.04 | 0.04 | ||
Support 4 (S4) | 0.04 |